ELAVL1 and breast neoplasm: Transcriptomic evaluation of TCGA breast tumor samples with high versus low ELAVL1 levels revealed that several genes from the glucose, TCA, fatty acid synthesis, beta-oxidation, and urea cycle pathways had altered expression levels (Fig. 1e, Supplementary Data 4).